Targeting EZH1/2: tackling epigenetic resistance advances cancer therapy

Targeting EZH1/2: tackling epigenetic resistance advances cancer therapy

Saved in:

Bibliographic Details
Main Authors:	Ram Abou Zaki, Assam El‐Osta
Format:	Article
Language:	English
Published:	Wiley 2025-01-01
Series:	MedComm
Online Access:	https://doi.org/10.1002/mco2.70022
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Atherogenic Factors and Their Epigenetic Relationships
by: Ana Z. Fernandez, et al.
Published: (2010-01-01)

Tackling somatic DNA contamination in sperm epigenetic studies
by: Anamika Kumari, et al.
Published: (2025-02-01)

Targeting the EZH2-PPAR Axis Is a Potential Therapeutic Pathway for Pancreatic Cancer
by: Jilong Hu, et al.
Published: (2021-01-01)

New Insights into the Androgen-Targeted Therapies and Epigenetic Therapies in Prostate Cancer
by: Abhijit M. Godbole, et al.
Published: (2011-01-01)

YPEL2 regulates the efficacy of BRD4-EZH2 dual targeting in EZH2Y641mut germinal center-derived lymphoma
by: Aránzazu Chamorro-Jorganes, et al.
Published: (2025-03-01)

Epigenetics of cancer drug resistance
by: Sayandeep Mukherjee, et al.
Published: (2023-07-01)

EZH2 serves as a viable therapeutic target for myeloma-induced osteolytic bone destruction
by: Rui Liu, et al.
Published: (2025-01-01)

Safety profile of EZH2 inhibitors for cancer: a systematic review and meta-analysis
by: Zhou Zhao, et al.
Published: (2025-01-01)

An epigenetic memory at the CYP1A gene in cancer-resistant, pollution-adapted killifish
by: Samantha Carrothers, et al.
Published: (2025-01-01)

Metabolic and epigenetic regulation of macrophage polarization in atherosclerosis: Molecular mechanisms and targeted therapies
by: Pinglian Yang, et al.
Published: (2025-02-01)

lncRNA HOTTIP Recruits EZH2 to Inhibit PTEN Expression and Participates in IM Resistance in Chronic Myeloid Leukemia
by: Jing Liu, et al.
Published: (2022-01-01)

Tackles and sidesteps
by: Herman Wasserman
Published: (2022-10-01)

Tackling Microbial Resistance and Emerging Pathogens with Next-Generation Antibiotics
by: Kar Jing Chong, et al.
Published: (2024-08-01)

Bone-Targeted Therapies in Metastatic Castration-Resistant Prostate Cancer: Evolving Paradigms
by: Joelle El-Amm, et al.
Published: (2013-01-01)

Differentiation therapy targeting the stalled epigenetic developmental programs in pediatric high-grade gliomas
by: Wang Xiang, et al.
Published: (2025-02-01)

Retracted: lncRNA HOTTIP Recruits EZH2 to Inhibit PTEN Expression and Participates in IM Resistance in Chronic Myeloid Leukemia
by: Stem Cells International
Published: (2023-01-01)

Molecular cloning of EZH2 oncogene in chronic myeloid leukemia and therapeutic prospects
by: Juliana Costa Gaspar, et al.
Published: (2015-07-01)

Advances in Ultrasound-Targeted Microbubble Destruction (UTMD) for Breast Cancer Therapy
by: Wu Y, et al.
Published: (2025-02-01)

Epigenetics and Breast Cancers
by: An T. Vo, et al.
Published: (2012-01-01)

High tackle headache: implications of referee agreement for tackle height law change
by: Carly D McKay, et al.
Published: (2025-01-01)

Long noncoding RNA-EBIC promotes tumor cell invasion by binding to EZH2 and repressing E-cadherin in cervical cancer.
by: Ning-xia Sun, et al.
Published: (2014-01-01)

Therapeutic Approaches to Tackle the Challenge of Depression That Is Resistant to Treatment–A Narrative Review
by: Md. Rajdoula Rafe, et al.
Published: (2025-01-01)

Tackling Waste Polystyrene with Sunlight
by: Hyun Suk Wang, et al.
Published: (2025-01-01)

Advances in the relationship between AP-1 and tumorigenesis, development and therapy resistance
by: Xinni Xue, et al.
Published: (2025-01-01)

Retraction: Long Noncoding RNA-EBIC Promotes Tumor Cell Invasion by Binding to EZH2 and Repressing E-Cadherin in Cervical Cancer.
by: PLOS One Editors
Published: (2025-01-01)

Fractional tackles: leveraging player tracking data for within-play tackling evaluation in American football
by: Quang Nguyen, et al.
Published: (2025-01-01)

Advances in Immunotherapy and Targeted Therapy of Malignant Melanoma
by: Xue Wang, et al.
Published: (2025-01-01)

GGCT participates in the malignant process of hepatocellular cancer cells by regulating the PTEN/PI3K/AKT pathway through binding to EZH2
by: Junbo He, et al.
Published: (2025-02-01)

Role of epigenetics in aetiology and therapies for Type 1 Diabetes Mellitus: A narrative review
by: Yahaya O Tajudeen, et al.
Published: (2019-07-01)

Interplay between Epigenetics and Genetics in Cancer
by: Jae Duk Choi, et al.
Published: (2013-12-01)

«Community Spirit» in Tackling Security Threats
by: N. V. Gavrilenko
Published: (2023-09-01)

Epigenetic Modifications and Potential New Treatment Targets in Diabetic Retinopathy
by: Lorena Perrone, et al.
Published: (2014-01-01)

SETD2 loss-of-function uniquely sensitizes cells to epigenetic targeting of NSD1-directed H3K36 methylation
by: Ryan T. Wagner, et al.
Published: (2025-02-01)

Advanced Fraud Detection: Leveraging K-SMOTEENN and Stacking Ensemble to Tackle Data Imbalance and Extract Insights
by: Nurafni Damanik, et al.
Published: (2025-01-01)

Targeted therapy and immunotherapy for gastric cancer: rational strategies, novel advancements, challenges, and future perspectives
by: Dong Luo, et al.
Published: (2025-02-01)

Nanomaterials for targeted therapy of kidney diseases: Strategies and advances
by: Zhiwen Wang, et al.
Published: (2025-04-01)

Targeting Fibrosis: From Molecular Mechanisms to Advanced Therapies
by: Xingpeng Di, et al.
Published: (2025-01-01)

Epigenetic Reprogramming of Muscle Progenitors: Inspiration for Clinical Therapies
by: Silvia Consalvi, et al.
Published: (2016-01-01)

EZH2 Might Affect Macrophage Chemotaxis and Anti-Inflammatory Factors by Regulating CCL2 in Dental Pulp Inflammation
by: Ziqi Hu, et al.
Published: (2021-01-01)

Expression of EZH2 and H3K27me3 predicts tumor biology of urothelial carcinoma
by: Rasheeda Mohamedali, et al.
Published: (2023-07-01)